Skip to main content

Nasal Congestion and Inflammations

1
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Ache Laboratorios Farmaceuticos
1 program
1
Group 1Phase 32 trials
Active Trials
NCT01393561Completed167Est. Dec 2014
NCT01199497Withdrawn0Est. Jan 2013

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Ache Laboratorios FarmaceuticosGroup 1
Ache Laboratorios FarmaceuticosGroup 1

Clinical Trials (2)

Total enrollment: 167 patients across 2 trials

NCT01393561Ache Laboratorios FarmaceuticosGroup 1

Efficacy and Safety of Combination of Brompheniramine and Phenylephrine for the Symptoms Relief of Rhinitis

Start: Jul 2014Est. completion: Dec 2014167 patients
Phase 3Completed
NCT01199497Ache Laboratorios FarmaceuticosGroup 1

Study to Evaluate the Efficacy and Safety of Fixed Dose Combination of Diphenhydramine + Pseudoephedrine + Dropropizine in the Control of Cough and the Relief of Nasal Symptoms, Suffering From Non-productive Cough and Acute Rhinitis

Start: Aug 2011Est. completion: Jan 20130
Phase 3Withdrawn

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.